Comorbidity measures for use with administrative data

被引:8090
作者
Elixhauser, A
Steiner, C
Harris, DR
Coffey, RN
机构
[1] MEDTAP Int Inc, Bethesda, MD 20814 USA
[2] US Dept HHS, Agcy Hlth Care Policy & Res, Ctr Org & Delivery Syst, Rockville, MD 20852 USA
[3] WESTAT Inc, Rockville, MD USA
[4] MEDSTAT Grp Inc, Washington, DC USA
关键词
comorbidity; administrative data; hospital resources; in-hospital mortality;
D O I
10.1097/00005650-199801000-00004
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
OBJECTIVES. This study attempts to develop a comprehensive set of comorbidity measures for use with large administrative inpatient datasets. METHODS. The study involved clinical and empirical review of comorbidity measures, development of a framework that attempts to segregate comorbidities from other aspects of the patient's condition, development of a comorbidity algorithm, and testing on heterogeneous and homogeneous patient groups. Data were drawn from all adult, nonmaternal inpatients from 438 acute care hospitals in California in 1992 (n = 1,779,167). Outcome measures were those commonly available in administrative data: length of stay, hospital charges, and in-hospital death. RESULTS. A comprehensive set of 30 comorbidity measures was developed. The comorbidities were associated with substantial increases in length of stay, hospital charges, and mortality both for heterogeneous and homogeneous disease groups. Several comorbidities are described that are important predictors of outcomes, yet commonly are not measured. These include mental disorders, drug and alcohol abuse, obesity, coagulopathy, weight loss, and fluid and electrolyte disorders. CONCLUSIONS. The comorbidities had independent effects on outcomes and probably should not be simplified as an index because they affect outcomes differently among different patient groups. The present method addresses some of the limitations of previous measures. It is based on a comprehensive approach to identifying comorbidities and separates them from the primary reason for hospitalization, resulting in an expanded set of comorbidities that easily is applied without further refinement to administrative data for a wide range of diseases.
引用
收藏
页码:8 / 27
页数:20
相关论文
共 33 条
  • [1] BENNETT CL, 1991, CANCER, V67, P2633, DOI 10.1002/1097-0142(19910515)67:10<2633::AID-CNCR2820671039>3.0.CO
  • [2] 2-9
  • [3] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [4] DesHarnais S, 1990, Int J Technol Assess Health Care, V6, P229
  • [5] ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES
    DEYO, RA
    CHERKIN, DC
    CIOL, MA
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) : 613 - 619
  • [6] Practical considerations on the use of the Charlson comorbidity index with administrative data bases
    DHoore, W
    Bouckaert, A
    Tilquin, C
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (12) : 1429 - 1433
  • [7] DHOORE W, 1993, METHOD INFORM MED, V32, P382
  • [8] Taking health status into account when setting capitation rates - A comparison of risk-adjustment methods
    Fowles, JB
    Weiner, JP
    Knutson, D
    Fowler, E
    Tucker, AM
    Ireland, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (16): : 1316 - 1321
  • [9] GONNELLA JS, 1984, JAMA-J AM MED ASSOC, V251, P637
  • [10] THE IMPORTANCE OF COEXISTENT DISEASE IN THE OCCURRENCE OF POSTOPERATIVE COMPLICATIONS AND ONE-YEAR RECOVERY IN PATIENTS UNDERGOING TOTAL HIP-REPLACEMENT - COMORBIDITY AND OUTCOMES AFTER HIP-REPLACEMENT
    GREENFIELD, S
    APOLONE, G
    MCNEIL, BJ
    CLEARY, PD
    [J]. MEDICAL CARE, 1993, 31 (02) : 141 - 154